Many experts believe telemedicine is primed for explosive growth, but healthcare organizations have more conservative expectations. That’s because, after heavily spending on electronic health records, providers are wary of committing money to telemedicine budgets, given a complex regulatory environment and reimbursement challenges. For its new report, “Defining Telemedicine’s Role: The View from the C-Suite,” Sage Growth Partners—a business management consulting firm—surveyed more than 100 C-suite healthcare executives about adoption rates, finances, return on investment and other important factors for selecting a telemedicine product. Here are the findings.
